Viewing Study NCT00421304


Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2026-01-01 @ 1:02 PM
Study NCT ID: NCT00421304
Status: COMPLETED
Last Update Posted: 2021-08-27
First Post: 2007-01-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness
Sponsor: MedImmune LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-01-10
Start Date Type: ACTUAL
Primary Completion Date: 2009-09-17
Primary Completion Date Type: ACTUAL
Completion Date: 2009-09-17
Completion Date Type: ACTUAL
First Submit Date: 2007-01-09
First Submit QC Date: None
Study First Post Date: 2007-01-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-08-02
Results First Submit QC Date: None
Results First Post Date: 2021-08-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2012-07-02
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2021-08-02
Last Update Post Date: 2021-08-27
Last Update Post Date Type: ACTUAL